Regeneron’s Billion-Dollar Catalyst Flying Under Wall Street’s Radar Ahead of Oct. 30 Earnings

Regeneron (NASDAQ:REGN) reports third-quarter results on Oct. 30. Regeneron books its full share of Dupixent profits from Sanofi (NASDAQ:SNY) for the first time this quarter. I think that change matters more than the market is giving it credit for. Dupixent’s Billion-Dollar Profit Drag Is Gone Last quarter, Regeneron posted non-GAAP EPS of $14.29 against an […]